$TFX — BUY 📊

$TFX — BUY 📊 Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applic 🎯 Q1 FY26 | Rev $1B | EPS $1.93 vs $3.75 🔴 💡 Consensus expected adjusted EPS of $3.75, implying stable high margins, but the miss to $1.93 reflects underestimation of deal-related noise, not fundamental deterioration. My variant view is that normalized run-rate EPS is $8–10, and the market's punitive repricing to ~16x P/E ignores the long-term compounding power and quality of the franchise. 📉 Reward/Risk: 1.83:1 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/TFX0618

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applic